Company Analysis

Hyperion DeFi, Inc. (HYPD)

Nasdaq: HYPD · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2016
Grade3.0
◀ Past 2.3● Present 1.9▶ Future 4.4
1 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

22 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Hyperion DeFi, Inc.’s names, not what it holds today.

Patents granted
22
22 utility, 1976 to Dec 31, 2025
Granted in 2025
4
Against 4 in 2024 and 1 in 2023
Applications published
25
2 of them in 2025
Names they are printed under
2
a former name
By yearGrantedApplications published
'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology11
Textile and paper machines1
Pharmaceuticals1
Handling1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Eyenovia, Inc. a former name
named as the applicant on its applications, in US
0 granted
24 published
Eyenovia, Inc. a former name
US, as the owner printed on each patent
22 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 9, 202512,490,932Ophthalmic drug deliveryMedical technologyEyenovia, Inc.
Sep 23, 202512,419,979Pulsed ultraviolet in-line sterilization system for primary drug containersHandlingEyenovia, Inc.
Apr 8, 202512,268,517Drop generating deviceMedical technologyEyenovia, Inc.
Feb 4, 202512,213,912Methods and devices for handling a fluid and delivering the fluid to the eyeMedical technologyEyenovia, Inc.
Dec 10, 202412,161,585Systems and devices for delivering fluids to the eye and methods of usePharmaceuticalsEyenovia, Inc.
Jul 9, 202412,029,682Spray ejector mechanisms and devices providing charge isolation and controllable droplet charge, and low dosage volume ophthalmic administrationMedical technologyEyenovia, Inc.
Jul 2, 202412,023,700Spray ejector device and methods of useMedical technologyEyenovia, Inc.
Mar 26, 202411,938,056Methods and devices for handling a fluid and delivering the fluid to the eyeMedical technologyEyenovia, Inc.
Dec 12, 202311,839,487Ophthalmic drug deliveryMedical technologyEyenovia, Inc.
Jul 26, 202211,398,306Ophthalmic drug deliveryMedical technologyEyenovia, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Aug 7, 20252025/0248842METHODS AND DEVICES FOR HANDLING A FLUID AND DELIVERING THE FLUID TO THE EYEMedical technologyEyenovia, Inc.
Feb 20, 20252025/0057692SYSTEMS AND DEVICES FOR DELIVERING FLUIDS TO THE EYE AND METHODS OF USEPharmaceuticalsEyenovia, Inc.
Aug 29, 20242024/0285430METHODS AND DEVICES FOR HANDLING A FLUID AND DELIVERING THE FLUID TO THE EYEMedical technologyEyenovia, Inc. · patent 12,213,912 granted from it
May 23, 20242024/0164708OPHTHALMIC DRUG DELIVERYMedical technologyEyenovia, Inc. · patent 12,490,932 granted from it
Jun 8, 20232023/0173118PULSED ULTRAVIOLET IN-LINE STERILIZATION SYSTEM FOR PRIMARY DRUG CONTAINERSHandlingEyenovia, Inc. · patent 12,419,979 granted from it
Dec 15, 20222022/0395221OPHTHALMIC DRUG DELIVERYMedical technologyEyenovia, Inc. · patent 11,839,487 granted from it
Nov 10, 20222022/0355329SPRAY EJECTOR DEVICE AND METHODS OF USEMedical technologyEyenovia, Inc. · patent 12,023,700 granted from it
Apr 28, 20222022/0125631METHODS AND DEVICES FOR DELIVERING PILOCARPINE TO THE EYE AS A MICRO-DOSE STREAM OF DROPLETSPharmaceuticalsEyenovia, Inc.
Mar 3, 20222022/0062035SPRAY EJECTOR MECHANISMS AND DEVICES PROVIDING CHARGE ISOLATION AND CONTROLLABLE DROPLET CHARGE, AND LOW DOSAGE VOLUME OPHTHALMIC ADMINISTRATIONMedical technologyEyenovia, Inc. · patent 12,029,682 granted from it
Dec 30, 20212021/0407663DROP GENERATING DEVICEMedical technologyEyenovia, Inc. · patent 12,268,517 granted from it
What it applied for, 2024 to 2025: Medical technology 3 · Pharmaceuticals 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton HYPD · research, not advice